-transparent.png){kind=logo}
Despite the progress made in screening for blood-transmitted diseases, both the post-infection diagnostic window and the appearance of novel infective agents remain critical issues for the safety of blood transfusions. Viral inactivation methodologies for fresh-frozen-plasma (e.g., treatment with methylene blue or solvent-detergent) are currently being compared, in terms of their activities on viral subtypes and coagulation factors, as well as general toxicity and clinical effects, in order to define the advantages, residual risks and the uncertainties involved in their use.
Related Publications
M Michel, and
R Zwahlen, and
B Brand
June 2000,
British journal of haematology,
M Michel, and
R Zwahlen, and
B Brand
October 1993,
BMJ (Clinical research ed.),
M Michel, and
R Zwahlen, and
B Brand
December 1993,
Annals of hematology,
M Michel, and
R Zwahlen, and
B Brand
January 2003,
British journal of biomedical science,
M Michel, and
R Zwahlen, and
B Brand
January 1993,
Beitrage zur Infusionstherapie = Contributions to infusion therapy,
M Michel, and
R Zwahlen, and
B Brand
January 2009,
U.S. Army Medical Department journal,
M Michel, and
R Zwahlen, and
B Brand
April 2021,
Zhongguo shi yan xue ye xue za zhi,
M Michel, and
R Zwahlen, and
B Brand
September 1987,
British medical journal (Clinical research ed.),
M Michel, and
R Zwahlen, and
B Brand
August 1987,
British medical journal (Clinical research ed.),
M Michel, and
R Zwahlen, and
B Brand
February 1986,
Critical care medicine,
